SlideShare a Scribd company logo
1 of 29
Dr. Rajendra Gode Institute of Pharmacy,
University - Mardi Road, Amravati - 444602
Presented by
SHRADDHA S. RAUT
B. Pharm
Guided by
DR. SACHIN PADOLE
M. Pharm, Phd (Pharmacology)
Pharmacy Council of India, New Delhi
PHARMACOLOGICAL AND TOXICOLOGICAL SCREENING
(MPL 103T)
“ Preclinical Screening of Antihypertensive Agent ”
1
 Contents :
2
Introduction
Screening of Antihypertensive agent
Animals used
Methods using In-vivo animal model
3
 Introduction
Preclinical Screening: It is the process by which potential drugs are identified and
optimized before undergoing in the process of clinical trial.
Aim: To collect data in support of the safety of the new treatment.
4
Hypertension: Increase in the arterial blood pressure above normal.
Conti……
Blood Pressure
Normal B.P. Chronic B.P.
Pre-hypertension B.P.
120/80
mmHg
STAGE 1: 150/100
mmHg
STAGE 2: 180/120
mmHg
> 200/150
mmHg
5
6
7
8
 Screening of Antihypertensive Agent
Antihypertensive agent : Drugs used to treat high blood pressure.
Animal models are developed
By utilizing etiological factors responsible for human hypertension
Excessive salt
intake
Hyperactivity of
RAAS
Genetic factors
 Animals Used :
9
Dog
b
Rat
SHR
b
10
Acute renal hypertension in rats
Chronic renal hypertension in rats
Chronic renal hypertension in dogs
Neurogenic hypertension in dogs
Fructose induced hypertension in rats
Genetic hypertension in rats
1
2
3
4
5
6
 Methods using in-vivo animal model
11
• Purpose and Rationale
1. Goldblatt proved that ischemia of kidney causes increase in BP by activating RAAS.
2. Hypertension is induced by clamping the left renal artery (2-Kidney 1-clip method)
• Procedure
Male Sprague Dawley rats weighing 300 g
anesthetized by i.p. injection of hexobarbital sodium (100mg/kg)
Dieffenbach clip is placed onto the left hilum of the kidney
1) Acute renal hypertension in rats
12
Conti……
The renal artery is occluded for 3.5 – 4 h
3.5 hr following the surgery, animals are anesthetized by
pentobarbital sodium (30-40 mg/kg, i.p.)
Trachea is cannulated to facilitate spontaneous respiration
To measure systolic and diastolic BP, the cannula in carotid artery is
connected to a pressure transducer
Jugular vein is cannulated to administer test compound
13
Conti……
After obtaining stable reduced BP values, the renal arterial
clip is removed
Leads to rise in BP due to increased plasma renin level
Within 15 min stable hypertension is achieved
Then test compound is administered by i.v. injection at
doses of 10 & 100 ug/kg
BP is monitored continuously
14
Conti….
• Evaluation
1. Increase in BP after reopening renal artery and decrease in BP after administration of
test compound is determined.
2. % inhibition is calculated by comparing pre-treatment and post-treatment BP values.
• Modification
Berthold et al. (1989) – BP associated with reflex bradycardia can be elicited by
injection of 5-HT into coronary artery.
James et al. (1975) – proved 5-HT as most powerful agent to induce hypertension.
15
• Purpose and Rationale
1. Based on findings of Goldblatt, various modifications are described.
2. This is one of the most effective modified method (1 Kidney-1 Clip method)
• Procedure
Male Sprague Dawley rats weighing 200-250 g
anesthetized by i.p. injection of pentobarbital (50 mg/kg)
Fur on back is shaved and skin is disinfected
2) Chronic renal hypertension in rats
16
Conti……
In left lumbar area, flank incision is made. Renal pedicel is exposed
Renal artery is dissected clean & U-shaped silver clip is slipped around it
near aorta
Right kidney is removed through incision and incision is closed by
wound clips
4-5 weeks after clipping, BP is measured
(Rat with >150 mmHg BP are selected)
BP readings are taken 3 days prior to drug treatment
17
Conti……
Drug is administered (10 ml/kg) for 3 days
Predrug and 2 hrs Postdrug BP readings are taken
• Evaluation
1. Activity is determined by comparing treatment BP values with control BP values
(Predrug BP of Day 1)
2. Comparison is done using paired t-test for evaluation of statistical significance.
• Modification
Duan et al. (1996) – induced renal hypertension in male Hartley Guinea Pigs by
ligation of left caudal renal artery & right nephrectomy
18
• Purpose and Rationale
1. Goldblatt -1st described the process by clamping renal artery.
2. Abram and Sobin – modified it as wrapping technique
• Procedure
Dogs weighing 10-12 kg anesthetized by i.v. injection of Thiopental (15 mg/kg)
midline abdominal incision is made (aseptic condition)
1 Kidney is exposed & wrapped in cellophane & then replaced
The contralateral kidney is exposed
3) Chronic renal hypertension in dogs
19
Conti……
The artery, vein and ureter are ligated and kidney is removed
The abdomen is closed by sutures and clips
BP is measured using tail-cuff method
(Dog with >150 mmHg BP are selected)
On day 1, readings are taken every 2 hr, just before treatment & 2-4 hr after treatment
with test compound
Drug administration is repeated for 5 days
On Day 3 & 4, BP readings are taken before and after treatment
20
Conti……
• Evaluation
The starting value is the average of 2 readings before administration of drug
Readings obtained after administration of drug is subtracted from this value
And recorded as fall of BP at various recording times
• Modification
Duan et al. (1996) - achieved renal hypertension by removing the renal capsule with gentle
traction
Abram & Sobin (1947) - induced hypertension by encapsulating both kidneys with latex
rubber capsules
21
• Purpose and Rationale
1. Vasomotor center is responsible for regulating BP.
2. By stimulating afferent buffer fibers, inhibitory influence is exerted on vasomotor
center, leads to acute neurogenic hypertension.
• Procedure
Adult Dogs weighing 10-15 kg anesthetized by i.v. injection of Thiopental (15 mg/kg)
femoral vein and artery is cannulated using polyethylene tubing to administer test
compound i.v.
Record arterial pressure and heart rate
4) Neurogenic hypertension in dogs
22
Conti……
Left ventricular pressure is recorded - by Millar microtip pressure transducer
Pmax is recorded - by speeding up chart paper
Cardiac output is determined - by Swan Ganz Catheter
All recordings are made with polygraph
Both carotid arteries are cleared up to bifurcation of internal ad external carotid arteries
Carotid sinus nerve are isolated, ligated and sectioned & bilateral vagotomy is performed to
produce neurogenic hypertension
Dog - allowed to equilibrate - for 30 min
23
Conti……
& bolus of test compound is administered through i.v.
H.R., arterial blood pressure, left ventricular pressure, Pmax are monitored for 90 min
• Evaluation
Changes of parameters are expressed as % of values before administration of drug.
• Modification
Angell James (1984) - described in rabbits
Krieger (1984) - described in rats
24
• Purpose and Rationale
Hwang (1987) - First reported that hypertension could be induced in normal rat by
feeding high-fructose diet
• Procedure
Male Wistar rats weighing 210-250 g
Housed 2 per cage on 12-hr night & 12-hr dark cycle
& are allowed free access to standard laboratory diet (Purina rat chow) & drinking fluid
(10% fructose solution)
5) Fructose induced hypertension in rats
25
Conti……
Body weight & Food and fluid intake is measured every week during
treatment
Using tail-cuff method, systolic BP and pulse rate is measured before
and every week during treatment
Blood sample is also taken to determine plasma glucose and insulin
• Evaluation
Statistical analysis is performed using one-way or two-way analysis of variance, followed
by Newman-Keuls test
• Modification
Hall et al. - reported effect of high-fat diet (for 6 weeks) on CV function in dogs.
26
• Survey
1. Smik and Hall – described inherited hypertension in rats
2. Okamoto (1963) – Spontaneous Hypertensive Rats (SHR) / Wistar-Kyoto Rats (WKY)
He also separated several sub-strains from SHR and named them as stroke prone strains
3. Bianchi – Milan Hypertensive Strains (MHS)
6) Genetic hypertension in rats
n m n
Male
(High BP)
Female (Slightly
elevated BP)
SHR / WKY
> 200 mmHg
27
Conti……
Dahl (1962) – developed inbreed strains named as DS (salt-hypertension-sensitive)
RD (salt-hypertension-resistant)
Deng and Rapp (1992) – increased BP of SHR is determined by multiple genetic loci
Peters (1993) – TGR27 as monogenetic model in hypertension research
• Assessment - Use of SHR to detect potential antihypertensive compound is well established.
• Modification
Pijel – described streptozotocin induced Diabetes Mellitus in SHR as a model for combined
effect of hypertension & diabetes
Linz et al. – proved that lifelong ACE inhibition doubled the lifespan in hypertensive rats
28
 References
1) Drug Discovery and Evaluation by H. Gerhard Vogel, 2nd edition, Springer
Publication, Pg no. 172 – 179
2) Handbook of Experimental Pharmacology by S. K. Kulkarni, 4th edition, Vallabh
Publication.
T H A N K
Y O U
29
Any question

More Related Content

What's hot

screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolytics
Sayanti Sau
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulators
Aanchal46
 

What's hot (20)

Screening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsScreening Models of Antidepressants Drugs
Screening Models of Antidepressants Drugs
 
Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
 
screening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsscreening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugs
 
Screening models for Parkinson & multiple sclerosis
Screening models for Parkinson & multiple sclerosisScreening models for Parkinson & multiple sclerosis
Screening models for Parkinson & multiple sclerosis
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agents
 
Antipsychotic screening models
Antipsychotic screening modelsAntipsychotic screening models
Antipsychotic screening models
 
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolytics
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
Screening of anti psychotic drugs salim
Screening of anti psychotic drugs  salimScreening of anti psychotic drugs  salim
Screening of anti psychotic drugs salim
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugs
 
Multiple sclerosis screening methods
Multiple sclerosis screening methodsMultiple sclerosis screening methods
Multiple sclerosis screening methods
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulators
 
screening model for diabetes
screening model for diabetesscreening model for diabetes
screening model for diabetes
 
Screening of Anxiolytics
Screening of AnxiolyticsScreening of Anxiolytics
Screening of Anxiolytics
 
Screening models of Anti diabetics.
Screening models of Anti diabetics.Screening models of Anti diabetics.
Screening models of Anti diabetics.
 
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
 

Similar to Preclinical Sreening of Antihypertensive agents.pptx

Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agents
Kanthlal SK
 
International Journal of Clinical & Experimental Hypertension
International Journal of Clinical & Experimental HypertensionInternational Journal of Clinical & Experimental Hypertension
International Journal of Clinical & Experimental Hypertension
SciRes Literature LLC. | Open Access Journals
 
Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...
Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...
Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...
iosrjce
 

Similar to Preclinical Sreening of Antihypertensive agents.pptx (20)

screening of antihypertensive drugs.pptx
screening of antihypertensive drugs.pptxscreening of antihypertensive drugs.pptx
screening of antihypertensive drugs.pptx
 
Antihypertensives.pptx
Antihypertensives.pptxAntihypertensives.pptx
Antihypertensives.pptx
 
Animal Models for anti-hypertensive Drugs
Animal Models for anti-hypertensive DrugsAnimal Models for anti-hypertensive Drugs
Animal Models for anti-hypertensive Drugs
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agents
 
Antihypertensive and antidiarrhoeal drugs preclinical screening
Antihypertensive and antidiarrhoeal drugs preclinical screeningAntihypertensive and antidiarrhoeal drugs preclinical screening
Antihypertensive and antidiarrhoeal drugs preclinical screening
 
Antihypertensive Screening Models
Antihypertensive Screening ModelsAntihypertensive Screening Models
Antihypertensive Screening Models
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agents
 
Screening of antihypertensiveagent by raunak
Screening of antihypertensiveagent by raunakScreening of antihypertensiveagent by raunak
Screening of antihypertensiveagent by raunak
 
screening method of cardiovascular activity
screening method of cardiovascular activityscreening method of cardiovascular activity
screening method of cardiovascular activity
 
Evaluation of Drugs used in CCF
Evaluation of Drugs used in CCFEvaluation of Drugs used in CCF
Evaluation of Drugs used in CCF
 
Evaluation of antihypertensive drugs
Evaluation of antihypertensive drugsEvaluation of antihypertensive drugs
Evaluation of antihypertensive drugs
 
sceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdfsceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdf
 
screening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsscreening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agents
 
Case study on CABG surgery
Case study on CABG surgeryCase study on CABG surgery
Case study on CABG surgery
 
Screening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsScreening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive Agents
 
Anti hypertensive
Anti hypertensive Anti hypertensive
Anti hypertensive
 
International Journal of Clinical & Experimental Hypertension
International Journal of Clinical & Experimental HypertensionInternational Journal of Clinical & Experimental Hypertension
International Journal of Clinical & Experimental Hypertension
 
PG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptxPG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptx
 
APPROACH TO HYPERTENSION.pptx
APPROACH TO HYPERTENSION.pptxAPPROACH TO HYPERTENSION.pptx
APPROACH TO HYPERTENSION.pptx
 
Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...
Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...
Bosentan Ameliorates Diabetic Angiopathy and Nephropathy in Streptozotocin-In...
 

More from ShraddhaRaut43

More from ShraddhaRaut43 (10)

Recent Advances in the treatment of Parkinson's Disease.pptx
Recent Advances in the treatment of Parkinson's Disease.pptxRecent Advances in the treatment of Parkinson's Disease.pptx
Recent Advances in the treatment of Parkinson's Disease.pptx
 
Computational Prediction of Protein Structure.pptx
Computational Prediction of Protein Structure.pptxComputational Prediction of Protein Structure.pptx
Computational Prediction of Protein Structure.pptx
 
History and Progress of Pharmacovigilance.pptx
History and Progress of Pharmacovigilance.pptxHistory and Progress of Pharmacovigilance.pptx
History and Progress of Pharmacovigilance.pptx
 
Regulatory Guidelines for Conducting Toxicity Studies by ICH.pptx
Regulatory Guidelines for Conducting Toxicity Studies by ICH.pptxRegulatory Guidelines for Conducting Toxicity Studies by ICH.pptx
Regulatory Guidelines for Conducting Toxicity Studies by ICH.pptx
 
Sex Hormones and Oral Contraceptives.pptx
Sex Hormones and Oral Contraceptives.pptxSex Hormones and Oral Contraceptives.pptx
Sex Hormones and Oral Contraceptives.pptx
 
Guidelines to the Preparation of document.pptx
Guidelines to the Preparation of document.pptxGuidelines to the Preparation of document.pptx
Guidelines to the Preparation of document.pptx
 
Application of Proteomic Science and Immunotherapeutics.pptx
Application of Proteomic Science and Immunotherapeutics.pptxApplication of Proteomic Science and Immunotherapeutics.pptx
Application of Proteomic Science and Immunotherapeutics.pptx
 
PNS Pharmacology - Local Anesthetics.pptx
PNS Pharmacology - Local Anesthetics.pptxPNS Pharmacology - Local Anesthetics.pptx
PNS Pharmacology - Local Anesthetics.pptx
 
Neurohumoral Transmission of Acetylcholine.pptx
Neurohumoral Transmission of Acetylcholine.pptxNeurohumoral Transmission of Acetylcholine.pptx
Neurohumoral Transmission of Acetylcholine.pptx
 
MPAT (MPL 101T) - Capillary Electrophoresis.pptx
MPAT (MPL 101T) - Capillary Electrophoresis.pptxMPAT (MPL 101T) - Capillary Electrophoresis.pptx
MPAT (MPL 101T) - Capillary Electrophoresis.pptx
 

Recently uploaded

Call Girls in Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in  Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in  Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Recently uploaded (20)

80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Call Girls in Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in  Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in  Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Uttam Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Philosophy of china and it's charactistics
Philosophy of china and it's charactisticsPhilosophy of china and it's charactistics
Philosophy of china and it's charactistics
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 

Preclinical Sreening of Antihypertensive agents.pptx

  • 1. Dr. Rajendra Gode Institute of Pharmacy, University - Mardi Road, Amravati - 444602 Presented by SHRADDHA S. RAUT B. Pharm Guided by DR. SACHIN PADOLE M. Pharm, Phd (Pharmacology) Pharmacy Council of India, New Delhi PHARMACOLOGICAL AND TOXICOLOGICAL SCREENING (MPL 103T) “ Preclinical Screening of Antihypertensive Agent ” 1
  • 2.  Contents : 2 Introduction Screening of Antihypertensive agent Animals used Methods using In-vivo animal model
  • 3. 3  Introduction Preclinical Screening: It is the process by which potential drugs are identified and optimized before undergoing in the process of clinical trial. Aim: To collect data in support of the safety of the new treatment.
  • 4. 4 Hypertension: Increase in the arterial blood pressure above normal. Conti…… Blood Pressure Normal B.P. Chronic B.P. Pre-hypertension B.P. 120/80 mmHg STAGE 1: 150/100 mmHg STAGE 2: 180/120 mmHg > 200/150 mmHg
  • 5. 5
  • 6. 6
  • 7. 7
  • 8. 8  Screening of Antihypertensive Agent Antihypertensive agent : Drugs used to treat high blood pressure. Animal models are developed By utilizing etiological factors responsible for human hypertension Excessive salt intake Hyperactivity of RAAS Genetic factors
  • 9.  Animals Used : 9 Dog b Rat SHR b
  • 10. 10 Acute renal hypertension in rats Chronic renal hypertension in rats Chronic renal hypertension in dogs Neurogenic hypertension in dogs Fructose induced hypertension in rats Genetic hypertension in rats 1 2 3 4 5 6  Methods using in-vivo animal model
  • 11. 11 • Purpose and Rationale 1. Goldblatt proved that ischemia of kidney causes increase in BP by activating RAAS. 2. Hypertension is induced by clamping the left renal artery (2-Kidney 1-clip method) • Procedure Male Sprague Dawley rats weighing 300 g anesthetized by i.p. injection of hexobarbital sodium (100mg/kg) Dieffenbach clip is placed onto the left hilum of the kidney 1) Acute renal hypertension in rats
  • 12. 12 Conti…… The renal artery is occluded for 3.5 – 4 h 3.5 hr following the surgery, animals are anesthetized by pentobarbital sodium (30-40 mg/kg, i.p.) Trachea is cannulated to facilitate spontaneous respiration To measure systolic and diastolic BP, the cannula in carotid artery is connected to a pressure transducer Jugular vein is cannulated to administer test compound
  • 13. 13 Conti…… After obtaining stable reduced BP values, the renal arterial clip is removed Leads to rise in BP due to increased plasma renin level Within 15 min stable hypertension is achieved Then test compound is administered by i.v. injection at doses of 10 & 100 ug/kg BP is monitored continuously
  • 14. 14 Conti…. • Evaluation 1. Increase in BP after reopening renal artery and decrease in BP after administration of test compound is determined. 2. % inhibition is calculated by comparing pre-treatment and post-treatment BP values. • Modification Berthold et al. (1989) – BP associated with reflex bradycardia can be elicited by injection of 5-HT into coronary artery. James et al. (1975) – proved 5-HT as most powerful agent to induce hypertension.
  • 15. 15 • Purpose and Rationale 1. Based on findings of Goldblatt, various modifications are described. 2. This is one of the most effective modified method (1 Kidney-1 Clip method) • Procedure Male Sprague Dawley rats weighing 200-250 g anesthetized by i.p. injection of pentobarbital (50 mg/kg) Fur on back is shaved and skin is disinfected 2) Chronic renal hypertension in rats
  • 16. 16 Conti…… In left lumbar area, flank incision is made. Renal pedicel is exposed Renal artery is dissected clean & U-shaped silver clip is slipped around it near aorta Right kidney is removed through incision and incision is closed by wound clips 4-5 weeks after clipping, BP is measured (Rat with >150 mmHg BP are selected) BP readings are taken 3 days prior to drug treatment
  • 17. 17 Conti…… Drug is administered (10 ml/kg) for 3 days Predrug and 2 hrs Postdrug BP readings are taken • Evaluation 1. Activity is determined by comparing treatment BP values with control BP values (Predrug BP of Day 1) 2. Comparison is done using paired t-test for evaluation of statistical significance. • Modification Duan et al. (1996) – induced renal hypertension in male Hartley Guinea Pigs by ligation of left caudal renal artery & right nephrectomy
  • 18. 18 • Purpose and Rationale 1. Goldblatt -1st described the process by clamping renal artery. 2. Abram and Sobin – modified it as wrapping technique • Procedure Dogs weighing 10-12 kg anesthetized by i.v. injection of Thiopental (15 mg/kg) midline abdominal incision is made (aseptic condition) 1 Kidney is exposed & wrapped in cellophane & then replaced The contralateral kidney is exposed 3) Chronic renal hypertension in dogs
  • 19. 19 Conti…… The artery, vein and ureter are ligated and kidney is removed The abdomen is closed by sutures and clips BP is measured using tail-cuff method (Dog with >150 mmHg BP are selected) On day 1, readings are taken every 2 hr, just before treatment & 2-4 hr after treatment with test compound Drug administration is repeated for 5 days On Day 3 & 4, BP readings are taken before and after treatment
  • 20. 20 Conti…… • Evaluation The starting value is the average of 2 readings before administration of drug Readings obtained after administration of drug is subtracted from this value And recorded as fall of BP at various recording times • Modification Duan et al. (1996) - achieved renal hypertension by removing the renal capsule with gentle traction Abram & Sobin (1947) - induced hypertension by encapsulating both kidneys with latex rubber capsules
  • 21. 21 • Purpose and Rationale 1. Vasomotor center is responsible for regulating BP. 2. By stimulating afferent buffer fibers, inhibitory influence is exerted on vasomotor center, leads to acute neurogenic hypertension. • Procedure Adult Dogs weighing 10-15 kg anesthetized by i.v. injection of Thiopental (15 mg/kg) femoral vein and artery is cannulated using polyethylene tubing to administer test compound i.v. Record arterial pressure and heart rate 4) Neurogenic hypertension in dogs
  • 22. 22 Conti…… Left ventricular pressure is recorded - by Millar microtip pressure transducer Pmax is recorded - by speeding up chart paper Cardiac output is determined - by Swan Ganz Catheter All recordings are made with polygraph Both carotid arteries are cleared up to bifurcation of internal ad external carotid arteries Carotid sinus nerve are isolated, ligated and sectioned & bilateral vagotomy is performed to produce neurogenic hypertension Dog - allowed to equilibrate - for 30 min
  • 23. 23 Conti…… & bolus of test compound is administered through i.v. H.R., arterial blood pressure, left ventricular pressure, Pmax are monitored for 90 min • Evaluation Changes of parameters are expressed as % of values before administration of drug. • Modification Angell James (1984) - described in rabbits Krieger (1984) - described in rats
  • 24. 24 • Purpose and Rationale Hwang (1987) - First reported that hypertension could be induced in normal rat by feeding high-fructose diet • Procedure Male Wistar rats weighing 210-250 g Housed 2 per cage on 12-hr night & 12-hr dark cycle & are allowed free access to standard laboratory diet (Purina rat chow) & drinking fluid (10% fructose solution) 5) Fructose induced hypertension in rats
  • 25. 25 Conti…… Body weight & Food and fluid intake is measured every week during treatment Using tail-cuff method, systolic BP and pulse rate is measured before and every week during treatment Blood sample is also taken to determine plasma glucose and insulin • Evaluation Statistical analysis is performed using one-way or two-way analysis of variance, followed by Newman-Keuls test • Modification Hall et al. - reported effect of high-fat diet (for 6 weeks) on CV function in dogs.
  • 26. 26 • Survey 1. Smik and Hall – described inherited hypertension in rats 2. Okamoto (1963) – Spontaneous Hypertensive Rats (SHR) / Wistar-Kyoto Rats (WKY) He also separated several sub-strains from SHR and named them as stroke prone strains 3. Bianchi – Milan Hypertensive Strains (MHS) 6) Genetic hypertension in rats n m n Male (High BP) Female (Slightly elevated BP) SHR / WKY > 200 mmHg
  • 27. 27 Conti…… Dahl (1962) – developed inbreed strains named as DS (salt-hypertension-sensitive) RD (salt-hypertension-resistant) Deng and Rapp (1992) – increased BP of SHR is determined by multiple genetic loci Peters (1993) – TGR27 as monogenetic model in hypertension research • Assessment - Use of SHR to detect potential antihypertensive compound is well established. • Modification Pijel – described streptozotocin induced Diabetes Mellitus in SHR as a model for combined effect of hypertension & diabetes Linz et al. – proved that lifelong ACE inhibition doubled the lifespan in hypertensive rats
  • 28. 28  References 1) Drug Discovery and Evaluation by H. Gerhard Vogel, 2nd edition, Springer Publication, Pg no. 172 – 179 2) Handbook of Experimental Pharmacology by S. K. Kulkarni, 4th edition, Vallabh Publication.
  • 29. T H A N K Y O U 29 Any question